Cargando…
Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
Glomerular basement membrane (GBM) damage plays a pivotal role in pathogenesis of albuminuria in diabetic nephropathy (DN). Heparan sulfate (HS) degradation induced by podocyte heparanase is the major cause of GBM thickening and abnormal perm-selectivity. In the present study, we aimed to examine th...
Autores principales: | An, Xiaofei, Zhang, Lin, Yuan, Yanggang, Wang, Bin, Yao, Qiuming, Li, Ling, Zhang, Jisheng, He, Ming, Zhang, Jinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527129/ https://www.ncbi.nlm.nih.gov/pubmed/28743882 http://dx.doi.org/10.1038/s41598-017-06844-2 |
Ejemplares similares
-
The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
por: Duan, Suyan, et al.
Publicado: (2023) -
Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission
por: Chen, Zhuyun, et al.
Publicado: (2017) -
Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage
por: Zhao, Yue, et al.
Publicado: (2017) -
Clinicopathological characteristics and outcome predictors of anti-glomerular basement membrane glomerulonephritis
por: Ge, Yifei, et al.
Publicado: (2022) -
Acute podocyte injury is not a stimulus for podocytes to migrate along the glomerular basement membrane in zebrafish larvae
por: Siegerist, Florian, et al.
Publicado: (2017)